Europe Tire Market Report 2016 Global Insulin Market Forecast to 2021

Global Insulin Market by Manufacturers, Regions, Type and Application, Forecast to 202

Title:Global Insulin Market by Manufacturers, Regions, Type and Application, Forecast to 2021
Insulin (from the Latin, insula meaning island) is a peptide hormone produced by beta cells of the pancreatic islets.
It regulates the metabolism of carbohydrates, fats and protein by promoting the absorption of, especially, glucose
from the blood into fat, liver and skeletal muscle cells.In these tissues the absorbed glucose is converted into either
glycogen via glycogenesis or fats (triglycerides) via lipogenesis, or, in the case of the liver, into both.Glucose
production (and excretion into the blood) by the liver is strongly inhibited by high concentrations of insulin in the
blood.Circulating insulin also affects the synthesis of proteins in a wide variety of tissues. It is therefore an anabolic
hormone, promoting the conversion of small molecules in the blood into large molecules inside the cells. Low
insulin levels in the blood have the opposite effect by promoting widespread catabolism.
Scope of the Report:
This report focuses on the Insulin in Global market, especially in North America, Europe and Asia-Pacific, South
America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and
application.
Market Segment by Manufacturers, this report covers
Novartis
Novo Nordisk
Boehringer Ingelheim
Bristol-Myers Squibb
Eli Lilly
MannKind
Sanofi
Merck
Bioton
GEA
Emisphere
Salix Pharmaceuticals
Gan & Lee
Dongbao
United Laboratories (TUL)
Takeda Pharmaceutical Company
Shihuida PHARMA Group
Henan Tian Fang Pharmaceutical
Disha Pharmaceutical Group
Market Segment by Regions, regional analysis covers
North America (USA, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America, Middle East and Africa
Market Segment by Type, covers
Ultra-short-acting insulin
Short-acting insulin
In effect insulin
Long-acting insulin
Market Segment by Applications, can be divided into
Type 1 diabetes
Type 2 diabetes
Others diabetes

Powered by www.marketresearchglobe.com

1/7